PNC Financial Services Group
WHWK

PNC Financial Services Group’s Whitehawk Therapeutics WHWK Stock Holding History

PNC Financial Services Group’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-368
Closed -$537 – 4940
2024
Q2 		$537 Sell
368
-11
-3% -$20 ﹤0.01% 4519
2024
Q1 		$887 Buy
+379
New +$731 ﹤0.01% 4387
2023
Q4 		– Sell
-245
Closed -$1.19K – 4785
2023
Q3 		$1.19K Buy
245
+89
+57% +$517 ﹤0.01% 4344
2023
Q2 		$1.07K Buy
+156
New +$1.21K ﹤0.01% 4494
2023
Q1 		– Sell
-12
Closed -$154 – 4844
2022
Q4 		$154 Buy
+12
New +$157 ﹤0.01% 4662

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group's WHWK Position: Q3 2024 in Review

PNC Financial Services Group sold out of Whitehawk Therapeutics (WHWK) in Q3 2024, closing a stake of 368 shares — an estimated $537 sold.

PNC Financial Services Group first reported a position in WHWK in Q4 2022 and held it in 5 quarters. The position peaked at $1.19K in Q3 2023. 52 funds tracked by Wall St. Rank hold WHWK as of Q3 2024.

  • PNC Financial Services Group reported no remaining Whitehawk Therapeutics position as of Q3 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 368 Whitehawk Therapeutics shares in Q3 2024, an estimated $537.
  • PNC Financial Services Group first reported a position in Whitehawk Therapeutics in Q4 2022 and held it in 5 quarters.
  • PNC Financial Services Group's Whitehawk Therapeutics position peaked at $1.19K in Q3 2023.
  • 52 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2024.

Based on PNC Financial Services Group's 13F filing for Q3 2024, filed 8 Nov 2024.